ID

44494

Descripción

A Phase I/II Study of HE3235 in Patients With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00716794

Link

https://clinicaltrials.gov/show/NCT00716794

Palabras clave

Versiones (2)
  1. 8/9/18 8/9/18 -
  2. 27/9/21 27/9/21 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

27 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00716794

Inglés

Eligibility Prostate Cancer NCT00716794

1 formularios  
Criteria
Descripción

Criteria

patient is male and at least 18 years of age, at the time of screening;
Descripción

Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
patient has metastatic disease (any t, any n, m1);
Descripción

Neoplasm Metastasis TNM clinical staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C3258246
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
Descripción

Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0215136
UMLS CUI [1,2]
C0040808
UMLS CUI [1,3]
C1265611
UMLS CUI [1,4]
C0231175
UMLS CUI [2,1]
C1328504
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C1328504
UMLS CUI [3,2]
C0231221
UMLS CUI [4,1]
C0392920
UMLS CUI [4,2]
C0919936
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
Descripción

Adenocarcinoma of prostate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007112
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
Descripción

Disease Progression | Hormone Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C0279025
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
Descripción

Prostate specific antigen measurement | Raised prostate specific antigen Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201544
UMLS CUI [2,1]
C0178415
UMLS CUI [2,2]
C1265611
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
Descripción

Evaluable Disease Progression

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516986
UMLS CUI [1,2]
C0242656
progression of metastatic bone disease on bone scan with > 2 new lesions
Descripción

Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C0449258
UMLS CUI [1,3]
C0203668
UMLS CUI [2,1]
C0221198
UMLS CUI [2,2]
C0205314
UMLS CUI [2,3]
C1265611
UMLS CUI [2,4]
C0203668
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
main exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
Descripción

Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C4277702
UMLS CUI [1,3]
C0231220
UMLS CUI [2,1]
C0228134
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C1514873
UMLS CUI [2,4]
C1520143
UMLS CUI [3,1]
C0228134
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C1522326
UMLS CUI [3,4]
C0683607
patient has active infection;
Descripción

Communicable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
Descripción

Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0018802
UMLS CUI [3]
C0086565
UMLS CUI [4]
C4018871
UMLS CUI [5]
C0151746
patient who has any clinically significant abnormalities in laboratory results at screening
Descripción

Laboratory test result abnormal

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0438215
patient who has a history of clinically significant neurological or psychiatric condition;
Descripción

Nervous system disorder | Mental condition Clinical Significance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027765
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C2826293
additional criteria are applicable to expansion cohorts.
Descripción

Criteria Additional | Cohort Expanded

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C1524062
UMLS CUI [2,1]
C0599755
UMLS CUI [2,2]
C0205229
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT00716794

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Gender | Age
Item
patient is male and at least 18 years of age, at the time of screening;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Neoplasm Metastasis TNM clinical staging
Item
patient has metastatic disease (any t, any n, m1);
boolean
C0027627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Taxane Regimen Quantity failed | CRPC Symptomatic | CRPC Asymptomatic | Chemotherapy naive
Item
patient has failed at least 1 taxane regimen; or patient has symptomatic or asymptomatic crpc and is chemotherapy-naïve
boolean
C0215136 (UMLS CUI [1,1])
C0040808 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,4])
C1328504 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C1328504 (UMLS CUI [3,1])
C0231221 (UMLS CUI [3,2])
C0392920 (UMLS CUI [4,1])
C0919936 (UMLS CUI [4,2])
Adenocarcinoma of prostate
Item
patient has histologically or cytologically confirmed adenocarcinoma of the prostate;
boolean
C0007112 (UMLS CUI [1])
Disease Progression | Hormone Therapy
Item
patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following:
boolean
C0242656 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
Prostate specific antigen measurement | Raised prostate specific antigen Quantity
Item
psa level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart.
boolean
C0201544 (UMLS CUI [1])
C0178415 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Evaluable Disease Progression
Item
evaluable disease progression by modified recist (response evaluation criteria in solid tumors) criteria;
boolean
C1516986 (UMLS CUI [1,1])
C0242656 (UMLS CUI [1,2])
Secondary malignant neoplasm of bone Progression Bone scan | Lesion New Quantity Bone scan
Item
progression of metastatic bone disease on bone scan with > 2 new lesions
boolean
C0153690 (UMLS CUI [1,1])
C0449258 (UMLS CUI [1,2])
C0203668 (UMLS CUI [1,3])
C0221198 (UMLS CUI [2,1])
C0205314 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0203668 (UMLS CUI [2,4])
ECOG performance status
Item
patient has ecog (eastern cooperative oncology group) performance status of 0-2;
boolean
C1520224 (UMLS CUI [1])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain Parenchymal Symptomatic | Epidural space Disease Requirement Whole brain radiation therapy | Epidural space Disease Treated allowed
Item
patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation treated epidural disease is allowed
boolean
C0220650 (UMLS CUI [1,1])
C4277702 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C0228134 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C1514873 (UMLS CUI [2,3])
C1520143 (UMLS CUI [2,4])
C0228134 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C0683607 (UMLS CUI [3,4])
Communicable Disease
Item
patient has active infection;
boolean
C0009450 (UMLS CUI [1])
Cardiovascular Disease | Congestive heart failure | Liver Dysfunction | Respiratory abnormality | Abnormal renal function
Item
patient having a history of clinically significant cardiovascular disease (such as chf), clinically significant hepatic, respiratory or renal abnormalities;
boolean
C0007222 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0086565 (UMLS CUI [3])
C4018871 (UMLS CUI [4])
C0151746 (UMLS CUI [5])
Laboratory test result abnormal
Item
patient who has any clinically significant abnormalities in laboratory results at screening
boolean
C0438215 (UMLS CUI [1])
Nervous system disorder | Mental condition Clinical Significance
Item
patient who has a history of clinically significant neurological or psychiatric condition;
boolean
C0027765 (UMLS CUI [1])
C3840291 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
Criteria Additional | Cohort Expanded
Item
additional criteria are applicable to expansion cohorts.
boolean
C0243161 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0599755 (UMLS CUI [2,1])
C0205229 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial